Diglyceride acyltransferase-2 (DGAT2) and coiled-coil domain-containing protein 69 (CCDC69) are two mRNAs that are lowly expressed in Her2-positive breast cancer and are involved in the risk scoring system. This evidence concerns the gene ERBB2 and breast carcinoma.